Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra

Rheumatology (Oxford). 2007 Dec;46(12):1860-2. doi: 10.1093/rheumatology/kem258. Epub 2007 Oct 25.

Authors

T Lequerré¹, O Vittecoq, S Pouplin, N Klemmer, O Mejjad, A Daragon, A M Prieur, X Le Loët

Affiliation

¹ Department of Rheumatology, Rouen University Hospital, 76031 Rouen Cedex, France. thierry.lequerre@univ-rouen.fr

PMID: 17965046
DOI: 10.1093/rheumatology/kem258

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Arthritis / drug therapy*
Arthritis / etiology*
Arthritis / physiopathology
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Interleukin 1 Receptor Antagonist Protein / therapeutic use*
Mevalonate Kinase Deficiency / complications*
Mevalonate Kinase Deficiency / diagnosis
Pain Measurement
Recovery of Function
Treatment Outcome

Substances

Interleukin 1 Receptor Antagonist Protein